Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Andreas Helke who wrote (3397)	6/30/1999 2:33:00 PM
From: LLCF	Respond to of 10280

<I wonder if biotech investing with its enormous price volatility and development risk makes sense> It all depends on price IMO. YTD a blind squirrel could have tripled the S&P... as long as he/she could get someone to cruise the SI boards for him/her. :) DAK

To: Andreas Helke who wrote (3397)	6/30/1999 4:55:00 PM
From: Harold Engstrom	Read Replies (3) \| Respond to of 10280

Andreas, I don't agree that "biotech stocks have essentially done nothing for the last few years." And you are definitely on the wrong board if you would expect Sepracor investors to jump onboard that statement - SEPR has exploded over the past few years. As has the stock of many other good biotech companies. The blind squirrel comment above seems pretty appropos: even if you don't have a clue you can read what some pretty bright people have to say here at SI and do very well for yourself. You know who they are!